TOPRA Offers New European Regulatory Affairs Course
TOPRA is offering a new European regulatory affairs course this month in Philadelphia and San Diego:
Philadelphia course date: April 19, 2010.
San Diego course date: April 23, 2010.
Target audience – Regulatory professionals and support staff in Regulatory Affairs and other related areas such as Medical, Manufacturing, Marketing etc. with a need to know European Regulatory Affairs. Suitable for staff in agencies and companies.
This is a new course, where you will have the opportunity to learn about European Regulatory Affairs direct from the source. These courses are limited to 30 attendees to ensure a relaxed informal environment with plenty of opportunity for interaction with the speakers.
The purpose of the day
The European Regulatory systems can be confusing and complex particularly for those not based in the European Union. The purpose of this course is to provide you with a clear and concise understanding of the European Regulatory environment including an overview of the key regulatory processes and procedures.
What you will learn
European Institutions and the European Legislative framework
European Clinical Trial Processes and Procedures
European Marketing Authorisation Processes and Procedures
The European system for classification of Post Approval Amendments
(Variations) and associated procedures.
Advertising, Labelling and Leaflets in the European Union
$400 - delegates will also receive free TOPRA membership until 1 January 2011 (Regulatory Rapporteur and InTouch Online only.)
Timings are 10 a.m. - 4 p.m. with breaks for morning coffee and lunch.
Venue:
Philadelphia, PA and San Diego, CA
Address:
Philadelphia, PA and San Diego, CA
Click here to register.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
